Authors:
Pierce, RA
Field, ED
Mutis, T
Golovina, TN
Von Kap-Herr, C
Wilke, M
Pool, J
Shabanowitz, J
Pettenati, MJ
Eisenlohr, LC
Hunt, DF
Goulmy, E
Engelhard, VH
Citation: Ra. Pierce et al., The HA-2 minor histocompatibility antigen is derived from a diallelic geneencoding a novel human class I myosin protein, J IMMUNOL, 167(6), 2001, pp. 3223-3230
Authors:
Vogt, MHJ
Goulmy, E
Kloosterboer, FM
Blokland, E
de Paus, RA
Willemze, R
Falkenburg, JHF
Citation: Mhj. Vogt et al., UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterizationof the critical polymorphic amino acid residues for T-cell recognition, BLOOD, 96(9), 2000, pp. 3126-3132
Authors:
Mutis, T
Gillespie, G
Schrama, E
Falkenburg, JHF
Moss, P
Goulmy, E
Citation: T. Mutis et al., Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease, NAT MED, 5(7), 1999, pp. 839-842
Authors:
Liem, LM
Fibbe, WE
van Houwelingen, HC
Goulmy, E
Citation: Lm. Liem et al., Serum transforming growth factor-beta(1) levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease, TRANSPLANT, 67(1), 1999, pp. 59-65
Authors:
Pierce, RA
Field, ED
den Haan, JMM
Caldwell, JA
White, FM
Marto, JA
Wang, W
Frost, LM
Blokland, E
Reinhardus, C
Shabanowitz, J
Hunt, DF
Goulmy, E
Engelhard, VH
Citation: Ra. Pierce et al., Cutting edge: The HLA-A0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique, J IMMUNOL, 163(12), 1999, pp. 6360-6364
Citation: T. Mutis et E. Goulmy, Induction of minor histocompatibility antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation - Response, BLOOD, 94(12), 1999, pp. 4376-4376
Authors:
Mutis, T
Verdijk, R
Schrama, E
Esendam, B
Brand, A
Goulmy, E
Citation: T. Mutis et al., Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens, BLOOD, 93(7), 1999, pp. 2336-2341